10
Mar
2017
Gottlieb on Deck at FDA, Editing Human Embryos, & Gilead Exec Rips PBMs
You may also like
Your account
Timmerman Report Gives You Consistent In-Depth Reporting on Biotechnology. Get Your Edge.
Corporate groups: E-mail me
Copyright 2017
Please don’t share full TR articles without permission. That hurts my business.
- Congrats Ben to you and your family! Take your time. https://t.co/7Jwmra9Lpn 3 hours ago
- RT @RESachs: Great initiative by FDA in an effort to use transparency (plus expedited review) to promote approval of/access to generic drug… 14 hours ago
- RT @ZacharyBrennan: Big: FDA updates generic drug prioritization to include generics for which there are fewer than three ANDAs approved ht… 15 hours ago
- RT @DShaywitz: New piece i really like - "Beware Tidy Success Narratives -- In Pharma And In Life" -> https://t.co/7xF4VSc5jw cc @ldtimmerm… 15 hours ago
Speaking Engagements
I am available to speak about biotech trends at public and private biotech events. See me for details.
Social Network
